[PLX] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -20.15%
YoY- -2,609.78%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 6,427 10,967 12,247 2,006 6,358 1,769 4,616 5.66%
PBT -11,241 -4,150 -7,743 -11,294 450 -10,736 -5,071 14.17%
Tax 128 38 3 75 3,045 213 43 19.91%
NP -11,241 -4,150 -7,743 -11,294 450 -10,853 -5,071 14.17%
Tax Rate - - - - -676.67% - - -
Total Cost 17,668 15,117 19,990 13,300 5,908 12,622 9,687 10.52%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -174.90 -37.84 -63.22 -563.01 7.08 -613.51 -109.86 8.05%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.25 -0.13 -0.52 -0.77 0.04 -0.11 -0.05 30.73%
EPS Diluted -0.25 -0.13 -0.52 -0.77 -0.60 -0.11 -0.05 30.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.